Associate professor Chris Xing received a $50,000 MC2 award from the Masonic Cancer Center for his project "A Highly Potent Chemopreventive Agent Blocking Tobacco Carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced Lung Tumorigenesis and Mechanisms."
